Keyphrases
Mammalian Target of Rapamycin Signaling
100%
Stress-induced
100%
Chronic Stress
100%
Depressive-like Behavior
100%
Monoacylglycerol Lipase Inhibition
100%
Chronic Mild Stress
83%
JZL184
83%
Hippocampus
66%
2-Arachidonoylglycerol (2-AG)
50%
Endocannabinoids
50%
Mammalian Target of Rapamycin (mTOR)
33%
Antidepressants
33%
Endocannabinoid System
33%
Monoacylglycerol Lipase Inhibitors
33%
Pathophysiology
16%
Genomic Deletion
16%
Adeno-associated Viral Vector
16%
Behavioral Abnormalities
16%
Pyramidal Neurons
16%
Synaptic Depression
16%
Biochemical Abnormalities
16%
Cannabinoid Receptor 1 (CB1R)
16%
Stress Coping
16%
Stress Decrease
16%
Monoacylglycerol Lipase
16%
Cre Recombinase
16%
Emotion-focused Coping
16%
Stress Dysregulation
16%
Mouse Model of Depression
16%
Depolarization-induced Suppression of Excitation
16%
Neuroscience
Behavior (Neuroscience)
100%
Mammalian Target of Rapamycin
100%
Acylglycerol Lipase
100%
Hippocampus
80%
Endocannabinoid
60%
2-Arachidonoylglycerol
60%
Antidepressant
40%
Lipase Inhibitors
40%
Endocannabinoid System
40%
Adeno Associated Virus Vector
20%
Gene Deletion
20%
Cre Recombinase
20%
Receptor
20%
Cannabinoid
20%
Biochemistry, Genetics and Molecular Biology
2-Arachidonoylglycerol
60%